Udo, R., Tcherny-Lessenot, S., Brauer, R., et al. (2016) The Risk of Acute Liver Injury Associated with the Use of Antibi-otics—Evaluating Robustness of Results in the Pharmacoepidemiological Research on Outcomes of Therapeutics by the European Consortium (PROTECT) Project. Pharmaco-epidemiology and Drug Safety, 25, 47-55.

has been cited by the following article:

• TITLE: Cefuroxime-Induced Hepatocellular-Cholestatic Hepatitis with Pancytopenia

  AUTHORS: Wolfgang Kunze, Jan-Peter Streidl, Thorsten Klemm, Juliane Lutze

  KEYWORDS: Cefuroxime, Hepatocellular-Cholestatic Hepatitis, Pancytopenia, Differential Diagnoses

  JOURNAL NAME: Open Access Library Journal, Vol.6 No.2, February 18, 2019

  ABSTRACT: Drug-induced liver injury is a rare event. We report on a 15-year old girl de-veloping jaundice and a maculopapular rash with pruritus after oral cefuroxime therapy. Liver enzymes as well as total bilirubin and direct bilirubin were elevated. After eliminating other causes of hepatitis, cefuroxime-induced hepatocellular-cholestatic hepatitis with pancytopenia was diagnosed and cefuroxime therapy was stopped. The patient recovered quickly and was discharged without complications. The prognosis of this side-effect of cefuroxime is generally favourable; lethal courses are rare.